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1. Introduction and Historical Perspective 
The worldwide evolution of robotic surgery continues to advance at a staggering pace.  In 
less than 20 years, the technology has grown exponentially from theoretical military 
application to daily use in operating rooms around the globe.  In fact, the overwhelming 
success of robotic surgery with regards to invention, innovation, and adaptation is an 
excellent example of collaboration between surgeons, industry, and government.  While the 
first  robotic device to be used clinically dates back to computerized tomography-guided 
stereotactic neurosurgery by Kwoh et al in 1988 1, the first urological application in a human 
was not described until Davies et al2 used a modified industrial robotic arm to perform a 
transurethral resection of the prostate three years later.  The first commercial application in 
laparoscopy did not come until the Automated Endoscopic System for Optimal Positioning 
(AESOPTM) was FDA approved in the United States in 19937.   Originally designed by the 
U.S. military, the table-mounted device could precisely guide a laparoscope and was later 
put into production by Computer Motion Inc. (Santa Barbara, California).3   Computer 
Motion Inc. would later introduce the ZEUSTM robotic system onto the U.S. market in 1998, 
just months after the unveiling of another surgical robot, the da Vinci® (Intuitive Surgical, 
Sunnyvale, California).  The da Vinci® system was born out of technology designed by 
NASA, also originally intended for use by the U.S. military, but quickly adopted for civilian 
use.  In 2003, Intuitive Surgical took over Computer Motion Inc., thereby paving the way for 
the da Vinci® robot, along with it’s newly FDA approved EndoWristTM, to dominate surgical 
robotic use worldwide.3  Today, the vast majority of published literature on robotic-assisted 
renal surgery has employed the use of the da Vinci® system, and it is the only commercially 
available master-slave robotic system in production today.  
Few studies have addressed the comparative performance and efficiency between the three 
most cited robotic platforms, namely AESOP, ZEUS and da Vinci®.  Sung et al4 initially 
looked at this question in a porcine model, and we later compared our results in a cohort of 
patients undergoing pyeloplasty for ureteropelvic junction obstruction (UPJO).5   Both 
groups concluded that the da Vinci® system was superior in terms of shorter operative time, 
quicker anastomotic time, and flatter learning curve.  We also found the majority of 
technical manoeuvering inherently more intuitive with the da Vinci® system compared to 
the ZEUS system.  There does exist some earlier reports of experience with the ZEUS O
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Telesurgical System by ourselves6 and others;7,8  however, the vast majority of published 
data in recent years has focused almost exclusively on the da Vinci® system.  And since the 
da Vinci® robot is the only master-slave robotic platform currently in production and 
available commercially, the focus of this chapter will center on this particular system as it 
applies to renal and adrenal surgical applications.  
While the field of urology was not the first medical discipline to embrace robotic technology, 
it has adopted the technology with open arms.  Through innovation and research, robotic-
assisted surgery is quickly becoming a routine tool in the urologist’s armamentarium.  
Currently, the majority of clinical indications for the da Vinci® system are for urological use.  
The majority of published research and clinical experience in the past has focused on robot-
assisted radical prostatectomy.3,9,10  However, the role of robotics in renal surgery continues 
to be defined.  With the exception of robot-assisted laparoscopic pyeloplasty (RALP), the 
majority of literary publications consist of case series and reports.  As such, the emphasis of 
this chapter will be on RALP.  For most other applications, the true role of robot-assisted 
renal surgery is yet to be defined.  Herein we focus on the indications, techniques, and 
surgical experiences described in the literature to date as it applies specifically to robotic-
assisted laparoscopic renal surgery.     
2. Nephrectomy and Nephroureterectomy 
Robot-assisted extirpative renal surgery has been described as a useful minimally invasive 
technique for both malignant and benign conditions.  While a standard laparoscopic 
approach is usually employed for nephrectomy and at most centers today,  robot-assisted 
technique are attractive to surgeons with minimal laparoscopic experience.  In contrast, 
most surgeons facile with basic laparoscopic skills have difficulty justifying the use of 
robotics for what is considered by many a relatively straightforward procedure.  Also, the 
da Vinci® system is not compatible with multi-fire clip appliers or standard endovascular 
stapling devices required for renovascular ligation and division, further discouraging 
routine use in the extirpative kidney surgery setting.9  
Following induction of general anesthesia, the patient is placed in a modified 60o lateral 
decubitus position with the affected side elevated.    Patients are placed on a clear fluid diet 
48 hours before surgery and receive an oral mechanical bowel prep the day before.  All 
pressure points are adequately padded and the patient fully secured to the operating table.  
Using standard laparoscopic techniques, intraperitoneal access is achieved with a 12-mm 
port for the laparoscope at the level of the umbilicus along the pararectus border on the 
affected side.  Two additional trocars are placed for docking the robotic arms in a typical 
triangle configuration as per standard laparoscopic nephrectomy (Figure 1).  A fourth port is 
placed at the umbilicus for the surgical assistant, to facilitate instrument exchanges, provide 
suction-irrigation, insert and remove suture material, and apply clips to the renal vessels 10.  
The entire dissection is carried out robotically with the surgeon positioned at the remote 
console.  Once the specimen is completely dissected, hemostasis is achieved with vascular 
staplers or clips.  The specimen is removed via extension of the most inferolateral trocar site 
or Pfannenstiel incision after endoscopic entrapment in a bag.  
A 12-mm camera port is placed just lateral to the rectus at the level of the umbilicus.  
Technique varies depending on surgeon preference.  Additional ports are placed after 
pneumoperitoneum is established. Two 8-mm robotic arm ports are then positioned 
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equidistant (approximately 8 to 10 cm or a handwidth) from the camera port at right angles 
to each other.  The surgical area of interest should falls in the center of the triangle created.  
A 12-mm assistant port is placed at the umbilicus.  An extra port can be placed subxiphoid 
as needed (ie. for liver retraction).  These recommendations may need adjustment on a case-
by case-basis depending on patient body habitus and clinical scenario.  
 
Figure 1. Recommended port placement for transperitoneal robot-assisted laparoscopic 
nephrectomy and adrenalectomy 
While Gill et al was the first to report the feasibility of robotic-assisted nephrectomy in a 
porcine model in 200011, the first published report in a human was described by 
Guillonneau et al12 the following year.  The patient was a 77-year-old woman with a 
hydronephrotic non-functioning kidney secondary to ureteropelvic junction obstruction 
(UPJO).  The ZEUS robotic surgical system was employed with total operating time of 
200 minutes and blood loss of less than 100 mL.  There were no peri-operative 
complications. Recently, Storm et al13 presented on 100 cases of robot-assisted 
laparoscopic nephrectomy.  Sixty-six were for suspicious renal masses and non-
functioning kidneys, and the remaining 34 were live donors.  Median operative time was 
170 minutes, estimated blood loss 100 mL, and length of hospital stay was 48 hours.  
Peri-operative complications occurred in five patients and included atelectasis, 
pancreatitis, wound infection, bowel injury, and a post-operative death.  There were 2 
conversions: one to hand-assisted laparascopic nephrectomy and the other to open 
nephrectomy.  The authors concluded robotic-assisted laparoscopic nephrectomy is safe, 
efficacious, and compares favorably with other minimally invasive techniques.  The 
authors did not comment on cost.     
While the need for robotic-assistance in simple and radical nephrectomy is questionable, 
reports employing the da Vinci® system in more complicated cases continue to be 
published.  Recently, Finley et al14 described combined robot-assisted 
nephroureterectomy with a hand-assist port followed by robot-assisted radical 
prostatectomy in a 57-year-old man.  Ureteric mobilization and excision of a cuff of 
bladder was performed robotically followed by standard robotic prostatectomy.  Lastly, 
nephrectomy was performed using a hand-assisted laparoscopy.  Total operative time 6.5 
hours, blood loss was 200cc, and the post-operative course was uneventful.  Nanigian et 
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al15 similarly describe a case serie of ten patients of robotic-assisted distal ureterectomy 
with a cuff of bladder and pure laparoscopic nephrectomy for a case of upper tract 
transition cell carcinoma.  These reports highlight the potential benefits of combining 
pure laparoscopic, hand-assisted laparoscopic, and robot-assisted laparoscopic 
techniques in complex cases.   
Employing a retroperitoneal technique, Rose et al16 described robot-assisted 
nephroureterectomy in two patients – one for a distal ureteric urothelial tumor and the 
other for a poorly functioning kidney with primary obstructed megaureter.  With a mean 
operative time of 182.5 minutes, blood loss of 75 mL, and no post-operative 
complications, the authors concluded this is a feasible approach in select patients. 
The observation that there have been limited published series in the literature on robot-
assisted laparoscopic radical or simple nephrectomy since the initial report by Guillonneau 
in 200112 underscores the tenuous role for robotics in this setting.  As experience with more 
complex combined upper and lower tract procedures are reported in the literature, the role 
for robotic-assistance in these settings will become further defined.   
3. Live Donor Nephrectomy 
The greatest experience with extirpative robot-assisted renal surgery involves live donor 
nephrectomy.  While some centers still consider open live donor nephrectomy the “gold 
standard”17, experience with laparoscopic donor nephrectomy, both purely laparoscopic 
and hand-assisted, continues to gain popularity.  Advantages of a minimally invasive 
approach include less post-operative pain, shortened hospital stay, and a quicker return to 
regular daily activities.18-20   Minimally invasive live donor nephrectomy is believed to have 
increased the donor pool by decreasing morbidity compared to open live donor 
nephrectomy.21   However, the technically demanding nature of laparoscopic live donor 
nephrectomy has made it an attractive candidate for robotic assistance.  Docking of the 
robotic arms, laparoscope, and assistant port is identical to that described for nephrectomy 
for other indications.  Special considerations include maximal preservation of renal vessel 
length, a Pfannenstiel extraction incision, and immediate cold flush on ice with an 
appropriate preservation solution.11 
Evidence exists that robotic-assisted live donor nephrectomy (RALDN) is safe, feasible, and 
with results equivalent to both open and other minimally invasive techniques.  Experience 
from four independent series is summarized in Table 1.  The first reported and most 
extensive series in the literature comes from the group at The University of Chicago.  
Horgan et al22 described their first 13 cases in 2002 and updated their data on 273 
consecutive RALDNs using a hand-assisted technique through April 2006.23   Their results 
from both donor and recipient perspectives are similar to other published live donor 
nephrectomy series and the authors acknowledge the evolution of their own surgical 
technique over time.  Talimini et al24 included their first 15 RALDNs in an early analysis of 
211 robotic-assisted surgeries, noting the safety, feasibility, and quick recovery associated 
with the da Vinci® robotic system.  Renoult and colleagues25 compared their initial 13 cases 
of RALDN with 13 matched open donor nephrectomies.  The only statistically significant 
differences between the groups were longer warm and cold ischemia times and longer 
operative times in the RALDN arm; however, the absolute differences were unlikely to be 
clinically significant.  Nonetheless, this does highlight the fact that a learning curve still 
exists with robotic-assisted techniques. 
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Author Year N 
Mean 
OR time 
(min) 
Mean 
WIT 
(sec) 
Mean 
LOS 
(days) 
Allograft 
outcome 
Complications 
Horgan 22 2002 12 166 79 1.9 No DGF 
C.diff colitis in 1 pt; 
wound infection in 
1 pt 
Talamini 24 2003 15 143 -- 1.0 
Not 
commented 
on 
None 
Renoult 25 2006 13 185 430 5.8 
POD 5 Mean 
ClCr = 62 
mL/min 
DVT in 1 pt 
Horgan 23 2007 273 150 98 2.3 
Mean Cr = 
1.4 mg/dL at 
6 mos 
Overall 9 “major”; 1 
death unrelated to 
OR 
WIT = warm ischemic time.  LOS = length of stay in hospital.  DGF = delayed graft function.  POD = 
post-op day.  ClCr = creatinine clearance.  DVT = deep venous thrombosis 
Table 1. A summary of published surgical series on robot-assisted live donor nephrectomy 
4. Partial Nephrectomy 
In an era when the majority of renal tumors are discovered incidentally via abdominal 
imaging for an unrelated indication,26 these tumors are frequently amenable to nephron-
sparing extirpative techniques.  Patients with exophytic lesions less than 4 cm are ideal 
candidates for partial nephrectomy in the elective setting.27   These techniques are further 
justified in patients with baseline compromised renal function, the potential for future renal 
deterioration, or a solitary kidney.28,29   In recent years, there has been an explosion of 
reports describing minimally invasive laparoscopic techniques for partial nephrectomy.30-34   
However, purely laparoscopic partial nephrectomy is technically challenging, and strategies 
to simplify resection and reconstruction while minimizing ischemic time have been sought.  
Theoretically, the enhanced ability to adjust resection angles facilitate intracorporal suturing 
with the EndoWristTM instruments has made robot-assisted partial nephrectomy (RALPN) 
an especially attractive alternative. 
To our knowledge, the first published feasibility report of RALPN was by Gettman et al in 
2004.35   Several authors have since described their technique and a number of these 
publications are summarized in Table 2.  All authors have used the da Vinci® surgical 
robotic system with a transperitoneal approach.  Some authors have advocated performing 
the initial dissection with standard laparoscopic or hand-assisted laparoscopic techniques, 
reserving the robot to facilitate resection of the tumor and reconstruction after hilar 
clamping.  Use and technique of intra-operative ultrasound, intra-operative frozen sections, 
argon beam coagulation, and adjuvant hemostatic agents differ between reports.  In 
Gettman’s series of 13 cases from the Mayo clinic, 8 cases employed an intra-renal artery 
occlusion balloon catheter for infusion of cooling solution.  The authors report the 
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angiocatheter provided effective arterial occlusion and prevented venous backflow in all 
cases.  However, others have questioned the cost, necessity, and invasiveness of this strategy 
in the absence of well-controlled prospective series looking at functional renal outcomes.36 
Author Year N 
Mean 
lesion 
size 
(cm) 
Mean 
OR 
time 
(min) 
Hilar 
clamp 
time 
(min) 
EBL 
(mL) 
Mean 
LOS 
(days) 
Complications 
Gettman 35 2004 13 3.5 215 22 170 4.3 1 post-op ileus 
Stifelman 105 2005 1 2.0 230 32 150 2.0 None 
Phillips 37 2005 12 1.8 265 26 240 2.7 
2 open conversions 
for bleeding; 1 
conversion for robot 
malfunction; 1 post-
op urine leak 
Caruso 36 2006 10 1.9 279 26 240 2.6 
2 conversions for 
bleeding, poor 
visualization; 1 
post-op urinary 
retention 
Kaul 38 2007 10 2.0 158 21  1.5 
None commented 
on 
EBL = estimated blood loss.  LOS = length of hospital stay. 
Table 2.  Summary of published reports of robot-assisted partial nephrectomy with the da 
Vinci® system 
Phillips et al37 described their initial experience with 12 RALPNs.  They highlighted the need 
for conversion in 3 patients (one of each to standard laparoscopy, hand-assisted laparoscopy, 
and open) and summarized advantages and disadvantages of robotic assistance in this setting.  
Specifically, the six degrees of freedom offered by the da Vinci® EndoWristTM, 3-D stereoscopic 
visualization, movement scale-down, negation of tremor, and console surgeon comfort were 
notable benefits.  Purported disadvantages included cost, set-up time, equipment malfunction, 
need for robotic training, lack of haptic feedback, and dependence on the table-side assistant at 
many critical points during the procedure.  Caruso et al36, in evaluation of their first 10 
RALPNs, found no convincing advantages of the robot over standard laparoscopic partial 
nephrectomy in experienced hands.  They no longer perform RALPN at their institution, but 
instead emphasize the need for a randomized study in this population.  Similarly, Kaul et al38 
summarized their initial 10 cases of RALPN at the Vattikuti Institute in Detroit.  Their results 
were similar to other small series in the literature with no conversions and no positive 
margins.  They also noted the need for larger evaluation in multi-center trials and 
recommended RALPN be performed by surgeons facile in advanced laparoscopy and robotics 
in order to minimize patient morbidity during the learning phase. 
While experience with robotic-assisted renal surgery continues to expand, the exact role of 
RALPN has yet to be defined.  Larger prospective studies with adequate follow-up are 
necessary to delineate whether or not a robotic approach is safe and effective compared to 
the “gold standard” open partial nephrectomy.  We must also keep in mind that all 
minimally invasive surgical techniques in this setting are still considered experimental at 
many centers. 
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5. Adrenalectomy 
The adrenal gland is particularly well suited for a laparoscopic surgical approach. Most adrenal 
lesions are small but often require a large incision for open surgical access. Since the first 
laparoscopic adrenalectomy by Gagner in 199239,40, a paradigm shift has taken place in favor of 
laparoscopic adrenalectomy versus the previous standard open approach. Similar to laparoscopic 
renal surgery, adrenalectomy has immeasurably improved the post-operative recovery in these 
patients.  Objective benefits have been proven regarding shorter hospital stay, reduced pain scores, 
and faster return to regular activities.41-45  To date, however, the robotic experience in this 
population is limited and the role for robotic-assisted adrenalectomy is not yet clear. 
Gill et al11 reported the first experience with robot-assisted laparoscopic adrenalectomy in a 
porcine model.  An inferior vena cava injury was repaired via intracorporal suturing without 
the need for conversion.  Young et al46 later performed a robotic-assisted adrenalectomy (RAA) 
for an incidental left adrenal mass in a patient being evaluated for a widened mediastinum.  
Final pathology revealed an adrenal oncocytoma.  In 2002, Bentas et al47 reported on four 
robotic-assisted transperitoneal adrenalectomies.  There were no complications or conversions.  
Similarly, Desai et al48 described their experience with two robot-assisted adrenalectomies, 
including one for pheochromocytoma.  There were no peri-operative complications and the 
patients were discharged home on post-op days 2 and 3, respectively.  In an interesting case 
report, St. Julien and colleagues49 recently reported a robot-assisted cortical-sparing 
adrenalectomy in an 18-year old male with Von Hippel-Lindau disease. The patient had 
presented with a metachronous pheochromocytoma of his remaining solitary adrenal.  There 
were no peri-operative complications and the patient did not require adrenal cortical 
replacement medication at follow-up.  Lastly, Winter et al50 recently published the largest 
series of robotic-assisted laparoscopic adrenalectomy to date.  The series of 30 patients had a 
median operative time of 185 minutes. They reported a 7% complication rate, including one 
patient with a prolonged ileus post-op and a brief episode of hypoxemia on the ward in 
another.  There were no open conversions and operative time decreased with increasing 
surgeon experience.  Mean length of hospital stay was 2 days.  According to their cost analysis, 
laparoscopic adrenalectomy was more economical compared to an open approach primarily 
because of shorter hospitalization, with only a slight difference in favor of standard 
laparoscopic versus robotic-assisted techniques ($11,599 versus $12,977, respectively).   
There are two reports in the literature comparing standard laparoscopic adrenalectomy and 
robotic adrenalectomy.  Brunaud et al51 evaluated their results of 14 robotic-assisted 
adrenalectomies with 14 standard laparoscopic adrenalectomies.  They found an overall longer 
mean operative time in the robotic arm (111 versus 83 minutes), but a progressive decrease 
with increasing experience.  They concluded no significant advantages to the robotic approach. 
However, they did highlight that an increased body mass index did not adversely affect the 
technique of robotic-assisted adrenalectomy, suggesting a possible benefit in larger patients. 
The same group reported a one-year follow-up quality of life study that did not show any 
difference between the two groups.52   Morino et al53 reported their experience with 10 robotic-
assisted adrenalectomies (two for pheochromocytoma) and compared them with 10 standard 
laparoscopic adrenalectomies.  Operative time was significantly longer in the robotic group 
(mean 107 versus 82 minutes) and there were no adverse peri-operative complications.  
However, four of the robotic cases were converted to standard laparoscopy for technical 
reasons.  Furthermore, cost was strongly in favor of the standard laparoscopic approach 
($2,737 versus $3,467).  Publications about RAA are summarized in Table 3. 
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Comments 
St. Julien 49 2006  1  0 0 NA 
Partial 
adrenalectomy on 
VHL patient  
Winter 50 2006  30 185 7 0 2 
RAA $12, 997 
LA $11, 599 
OA $14, 600 
LA 10 82 0 0 5.4 $2, 737 
Morino 53 2004 
RAA 10 107 20 40 to LA 5.7 $3, 467 
LA 14 83 21 7  
Brunaud 51 2003 
RAA 14 111 21 7  
Similar Q of L 52 
D’Annibale106 2004  1 110 0 0 2  
Desai 48 2002  2 135 0 0 2.5  
Bentas. 47 2002  4 220 0 0 5  
Young 46 2002  1 100 0 0 1  
LA = laparoscopic adrenalectomy.  RAA = robot-assisted adrenalectomy. OA = open adrenalectomy. 
LOS = length of stay in hospital. Q of L = quality of life. NA = non available 
Table 3.  Summary of published reports of robot-assisted adrenalectomy with the da Vinci® 
robotic system 
6. Pyeloplasty 
Open dismembered pyeloplasty is the gold standard treatment for adult ureteropelvic 
junction obstruction (UPJO) with published success rates consistently over 90%.54,55  
However, the morbidity of an open flank incision led to experimentation with other less 
invasive modalities such as endopyelotomy and laparoscopic techniques.  Following the 
first description by Schuessler et al56, modern laparoscopic pyeloplasty series consistently 
demonstrate equivalent success rates to open series with improved postoperative 
convalescence.57-62   The need for complex intracorporeal reconstruction has limited the 
widespread application of standard laparoscopic pyeloplasty, thereby paving the road for a 
robotic-assisted approach.  The da Vinci® surgical robotic platform offers features that 
simplify intracorporeal reconstruction and suturing, thereby shortening the learning curve 
for residents, clinical fellows, and other novice laparoscopists alike.  
Sung and colleagues4,63 were the first to explore the feasibility of robotic-assisted 
laparoscopic pyeloplasty (RALP) in pigs.  Guillonneau64 later confirmed the technical 
feasibility and safety of a robotic approach in an animal model.  The first clinical experience 
in humans was reported in 2002 by Gettman et al,65,66  and provided satisfactory short-term 
results in a small number of patients.  Since then, several other groups have reported their 
experience with robotic-assisted laparoscopic pyeloplasty.  These reports are summarized in 
Tables 4 and 5.  
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Diagnosis of UPJO is based on clinical presentation (ie. renal colic, febrile urinary tract 
infection) and imaging studies.  Traditional diagnostic investigations include excretory 
urogram, renal ultrasound, and CT, classically revealing hydronephrosis with a non-dilated 
ureter and no obvious cause for obstruction (ie. stone or tumor).  Functional obstruction is 
typically confirmed by furosemide-nuclear renogram, providing information on the degree 
of obstruction and split renal function.  It also serves as a baseline if surgical intervention is 
planned.  In select cases, if a primary endoscopic treatment is planned, the presence of a 
crossing vessel can be established usisng CT 67, Magnetic Resonance Imaging (MRI) 68 or 
contrast-enhanced Doppler ultrasonography.69-71  
The indications for RALP are the same as standard laparoscopic or open pyeloplasty. RALP has 
been performed safely and effectively in patients with primary UPJO or secondary UPJO 
following a failed previous repair.72-75   RALP in pelvic and horseshoe kidneys has been 
reported with good results.72,74,76   Also, the robotic approach can be used to successfully 
manage concomitant renal stones at the time of the surgery.74,76-78   Contraindications to RALP 
are the same as standard laparoscopic pyeloplasty and include poor renal function, poor 
surgical candidate, uncorrected coagulopathy, abdominal wall infection, and bowel obstruction. 
The technique for RALP has been well described in a number of reports.  At our center, all 
patients receive a full mechanical bowel preparation the day before surgery.  Prophylactic 
antibiotics are administered 30-60 minutes before the initial incision and deep venous 
thrombosis prophylaxis is routinely employed based on patient risk stratification (sequential 
compression device or thrombo-embolic stockings +/- subcutaneous heparin). 
 
Figure 2. Pre-operative retrograde pyelogram demonstrating findings consistent with a right 
ureteropelvic junction obstruction 
The use of an indwelling ureteral stent is recommended, but the timing and method of 
placement is based on surgeon preference.  At our institution, after induction of general 
anesthesia we perform a retrograde pyelogram with the patient supine to confirm the 
diagnosis (Figure 2).  The UPJ is localized and the overlying skin is marked for future 
reference and as a guide for port-placement.  A double-“J” ureteral stent is then inserted 
under fluoroscopic guidance.74,79-81   A 3-way bladder catheter is inserted and connected to a 
1-litre bag of sterile normal saline with methylene blue.  Some authors prefer an indwelling 
5-French open-ended ureteral catheter prepped in the surgical field.  This can later be used 
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to exchange for a double-“J” stent with a guide wire under laparoscopic visualization.77,82,83   
Finally, others prefer to insert a double-“J” stent antegrade over a guidewire through the 
assistant port72,76,84 or through a large-bore angiocath directly through the abdominal wall in 
a subcostal position.85   With these latter strategies, it is recommended to confirm proper 
placement of the distal end of the stent intra-operatively by filling the bladder and 
observing for reflux laparoscopically.  Alternatively, cystoscopy can be performed intra-
operatively or placement confirmed with a single abdominal film in the recovery room. 
Once the double-“J” stent placement is confirmed, the patient is placed and secured in a 
modified 60° lateral decubitus position with a beanbag and tape.  We do not routinely flex 
the table and we ensure that all pressure points are padded appropriately.  An orogastric 
tube is useful to decompress the stomach and increase the working spaces for left-sided 
procedures.  Figure 3 give an overview of the operating room setup. Pneumoperitoneum is 
achieved with a Veress needle or Hasson trochar and the initial 12-mm port is placed at the 
umbilicus.  Most authors use this port for the laparoscope. Two additional 8-mm robotic 
arm ports are then placed so as to form an isosceles triangle with the base facing laterally 
(Figure 4).  Depending on surgeon preference, a 12-mm assistant-port is placed either 
subxyphoid, inferior to the camera port, or just caudal to McBurney’s point on the ipsilateral 
side.  This port can be used for suction-irrigation, to help with retraction, introducing and 
removing suturing material, and placement of a double-“J” stent.  Nephroscophy and basket 
stone extraction can also be performed through this port as needed.  Some authors, 
especially in the pediatric setting, use only 3 ports altogether.74,85,86  
  
Figure 3. Operating room setup for robotic-assisted laparoscopic pyeloplasty 
The patient is placed in a 60° lateral decubitus position. After port placement, the da Vinci® 
system is positioned over the patient’s ipsilateral flank.  The primary surgeon is seated at 
the remote surgical console.  The surgical assistant is situated on the contralateral side across 
from the robot.  A scrub nurse is near the foot of the bed.  A monitor is positioned in view of 
the surgical assistant and scrub nurse. The anesthesiologist is at the head of the table. 
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A 12-mm camera port is placed at the umbilicus.  Two robotic arm ports are then placed to 
create a triangle with the base facing laterally.  A 12-mm assistant port can be placed as per 
surgeon preference -- subxyphoid, just medial to the camera port, or caudally in the vicinity 
of McBurney’s point.  
 
Figure 4. Port placement for transperitoneal robot-assisted laparoscopic pyeloplasty, as 
usually described in the literature 
Our own technique is a somewhat different. We use a 12-mm umbilical port for the 
assistant.  The laparoscope is placed at the skin marker previously set during retrograde 
pyelography.  This point usually lies along the anterior axillary line.  We then place two 
additional 8-mm robotic arm ports to create an isosceles triangle with the base facing 
medially (Figure 5).  We feel this technique allows more freedom for the assistant to 
maneuver.  The subxiphoid position is often constrained by the patient’s arm and a too-
medial position often is restricting due to nearby loops of bowel. 
A 12-mm port is inserted at the umbilicus as described by Hassan and pneumoperitoneum 
is established. This serves as the assistant’s.  A second 12-mm camera port is placed lateral at 
the estimated location of the UPJ.  Lastly, two robotic arm ports are placed medial to camera 
port so as to create a triangle with the base facing medially.  
 
Figure 5. Port placement for transperitoneal robot-assisted laparoscopic pyeloplasty as per 
Luke’s modification 
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Using the da Vinci® platform, all steps of traditional Anderson-Hynes dismembered 
pyeloplasty, Y-V plasty and Fenger-plasty can be performed.65,72,74,77,87   We usually 
employ a dismembered technique as we believe this provides the best results in open 
and standard laparoscopic pyeloplasty.  It also allows versatility in almost all clinical 
scenarios, including crossing vessels, renal calculi, a large pelvis that needs to be 
reduced, and secondary repairs.88   A standard set of laparoscopic instruments is 
required in addition to the robotic ones, namely monopolar hook cautery, forceps, 
needle drivers and scissors.  
Some authors described a hybrid approach whereby the initial dissection of the colon, 
renal pelvis and proximal ureter is performed using standard laparoscopic techniques, 
reserving the robot for the ureteropelvic anastomosis.74,77,83,84,89   We routinely perform 
the entire procedure robotically to minimize operative time changing and exchanging 
instruments.  The robot is positioned on the ipsilateral side of the patient, angled over 
their exposed flank and the three robotic arms are engaged with the working ports and 
the camera port (Figure 6).  For right-sided UPJO, the line of Toldt is incised and the 
hepatic flexure is retracted medially to identify Gerota’s fascia.  For left-sided UPJO, the 
standard approach similarly involves incision of the line of Toldt and medial 
mobilization of the descending colon to expose Gerota’s fascia.  In thin or pediatric 
patients with left-sided UPJO, an alternative transmesenteric approach has been 
described.72,74,85,86,90  The ureter is identified distally and followed cephalad to the UPJ.  
The UPJ itself and any associated crossing vessels are then dissected free.  If renal 
calculi are present,74,76-78 a small pyelotomy incision is made at the UPJ and flexible 
nephroscopy and stone extraction are performed through the assistant port.  Stones are 
removed via basket extraction or placed in an extraction bag, depending on size and 
number.  Next, the UPJ is transected, the stenotic segment is excised, and the ureteral 
end is spatulated laterally.  The proximal end of the stent is removed from the renal 
pelvis and, if necessary, the pelvis is reduced by a diamond-shape excision.  If an 
anterior crossing vessel is present, the renal pelvis is transposed anterior to the vessel 
and the posterior aspect of the anastomosis is performed with a running 5–0 
polydioxanone suture, cut to 15 cm in length.  The proximal end of the stent is then 
replaced into the renal pelvis.  The anterior wall of the anastomosis is completed with a 
second running suture.  Occasionally there is some redundancy of the proximal renal 
pelvis necessitating a third running suture for adequate closure.  We then fill the 
bladder with the methylene blue saline solution to assess for reflux and ensure the 
anastomosis is watertight.  Any obvious leak is corrected with additional suture.  Once 
hemostasis is achieved and confirmed at low insufflation pressure, a 7-mm Jackson-
Pratt close-suction drain is inserted through one of the 8-mm ports once the robot is 
undocked.  The fascia of the 12-mm ports and skin are re-approximated as per surgeon 
preference. 
Postoperative management is usually uneventful.  The bladder catheter is removed in 1-
2 days.  The close-suction drain is then removed if there is no significant increase in 
output with spontaneous voiding.  Patients are discharged home on post-operative day 
1 or 2 pending no complications.  We typically remove the ureteral stent 4 weeks post-
op.  A follow-up furosemide-nuclear renogram is performed at approximately 10 weeks 
and 6 months post-operatively.  Follow-up ultrasound is obtained in pediatric patients, 
reserving a renogram for select cases or surgeon preference.  Some authors prefer repeat 
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imaging on an annual basis.  In the context of normal post-operative imaging and no 
symptoms we usually stop follow-up at 6 months, recognizing that late recurrence in 
this setting is rare.61 
 
Figure 6. Port placement and robot docking position for a patient undergoing a right robotic 
pyeloplasty 
There is an expanding body of literature on RALP, a summary of which is presented in 
Table 4. Comparative studies between RALP and open or standard laparoscopic pyeloplasty 
are summarized in Table 5.  Schwentner et al72 reported on the largest series of RALP with a 
relatively long median follow up of 39 months.  All 92 patients underwent Anderson-Hynes 
dismembered RALP.  Twelve patients had secondary UPJO and 2 patients had a horseshoe 
kidney. There were no intra-operative complications and no open conversion.  Anterior 
crossing vessels were found in 45 patients (49%).  The mean operative time was 108 minutes, 
including time to dock and undock the robot.  As similarly reported by many other 
authors,72,74,77,84,87,90,91 their operative time decreased significantly with increased experience 
of the surgical team and the technical staff.  The mean anastomotic time was only 25 minutes 
and the average blood loss was less than 50 ml.  There were three notable post-operative 
complications: one patient developed clot colic requiring stent exchange and percutaneous 
nephrostomy; another patient bled into the collecting system that was managed non-
operatively; and one patient developed a prolonged urine leak managed conservatively. The 
mean hospital stay was 4.6 days and the overall success rate was 96.7%.  
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DM = dismembered. FP = Fenger-plasty. UPJO = ureteropelvic junction obstruction. LOS = length of 
stay in hospital. UTI = urinary tract infection. LP = laparoscopic pyeloplasty.  RALP = robot-assisted 
laparoscopic pyeloplasty. OP = open pyeloplasty. LOS = length of stay in hospital. Q of L = quality of 
life. NA = non available 
Table 5.  Summary of published reports comparing robot-assisted pyeloplasty with the da 
Vinci® system to standard laparoscopic pyeloplasty or open pyeloplasty 
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Patel et al87 published a series of 50 patients with a median follow up of 11.7 months.  
There were no post-op complications and most patients went home on post-operative 
day one. Ninety-six percent had both objective and subjective improvement.  As shown 
in Table 4 and in a recent publication by Shah and colleagues,79 most series report 
operative times between 108 to 300 minutes and estimated blood loss from 30 to 100 ml.  
Complications ranged from 0 to 11% and include urine leak, urinary tract infection, 
stent migration, port site hernias, hemorrhage and hematoma.  One group92 reported a 
gluteal compartment syndrome in an obese patient following a long procedure at the 
beginning of their experience.  Another group86 reported missing a crossing vessel 
during a retroperitoneal RALP in a child.  A second transperitoneal RALP was 
performed successfully.  Most authors considered subjective improvement in symptoms 
and improved drainage on furosemide-nuclear renogram as markers for success.   
Reported success rates vary from 94 to 100%. Subgroup analysis by some authors 
reported comparable results for high-risk patients including secondary UPJO, UPJO in a 
horseshoe kidney, concomitant pelvicalyceal calculi, and infants less than 3 months 
old.75,83,85,86,93   In an interesting case report Yee and colleagues described a robot-
assisted reconstruction of a post-traumatic urteropelvic junction disruption.  The 
procedure was performed one month after the injury with a satisfactory result.94 
Based on these and other publications directly comparing RALP with open or standard 
laparoscopic pyeloplasty, we conclude that the robotic approach appears safe and 
effective (see Table 5).  Intermediate-term results are slowly accumulating in the 
literature and compare favorably with open pyeloplasty results.  Unfortunately, as with 
other applications of robotic-assisted surgery, the biggest drawback and criticism 
centers on the purported lack of cost-effectiveness compared to other less expensive 
modalities.80,95-97   
7. Other Applications of Robotic-assisted Renal Surgery 
There are numerous case reports and a few case series in the literature describing novel 
and innovative applications of surgical robots.  A few examples of these applications 
have been described specifically pertaining to renal surgery.   
Luke et al98 described a technique of robotic-assisted renal artery aneurysm resection 
and reconstruction using the da Vinci® sytem.  The patient was a 54-year-old male with 
a serially expanding 2.5-cm incompletely calcified saccular renal artery aneursym on the 
left side (Figure 7).  Using a 5-trochar technique, the entire dissection, resection and 
end-end anastomotic reconstruction was carried out robotically (Figure 8).  A 
saphenous vein interposition graft was harvested but not needed during the 
reconstruction. Total operative time was 360 minutes, warm ischemic time was 59 
minutes, and arterial anastomotic time was 10.5 minutes.  The estimated blood loss was 
650 mL and the post-operative course was uneventful.  At 2 months follow-up split 
renal function on renal scan was 55:45 for right and left, respectively. Follow-up CT-
scan performed two years after surgery showed complete absence of aneurysmal 
dilatation and prompt, complete uptake of contrast by the kidney (Figure 9). 
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a) 
 
b) 
Figure 7. a) Preoperative renal angiography demonstrates a calcified 2.5 cm left-sided 
saccular aneurysm. b) Preoperative abdominal CT scan shows the hilar location of the renal 
aneurysm (white arrow) 
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a) 
 
b) 
Figure 8. a) Videoscopic view of the renal artery aneurysm during its excision with the 
laparoscopic scissors. b) Videoscopic view during robotic-assisted reconstruction of the 
anterior wall of the renal artery 
 
Figure 9. Follow-up abdominal CT scan performed 30 months postoperatively, confirming 
resolution of the aneurysm and prompt arterial flow to the left kidney 
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Hoznek et al99 have described a robotic-assisted kidney transplant.  The recipient was 26-
year-old male with end-stage renal disease secondary to focal segmental glomerulosclerosis 
and a prior rejected transplant.  The allograft was a right kidney with inferior vena cava 
reconstruction from a heart-beating cadaveric donor.  The surgical assistant made a left 
lower quadrant Gibson incision, developed the retroperitoneal working space, positioned 
the retractor, provided cautery hemostasis, and placed vascular clamps.  The external iliac 
arterial and venous dissections and the vascular anastomoses were performed entirely by 
the console surgeon.  A Lich-Gregoir ureteroneocystostomy was also performed robotically.  
Cold ischemia time was over 26 hours, operative time was 178 minutes, and anastomotic 
time was 57 minutes.  Delayed graft function secondary to acute tubular necrosis resolved 
after one week and there was satisfactory graft function at two months.    
Orvieto et al100 described robotic-assisted reconstruction of a strictured tranplant ureter.  The 
patient was a 35-year-old recipient of a combined kidney-pancreas transplant.  An extensive 
allograft ureteric stricture was diagnosed following recurrent urinary tract infections and an 
episode of urosepsis.  The da Vinci® robot was employed for pyeloureterostomy from the 
allograft renal pelvis to the native ureter.  The initial right lower quadrant dissection was 
performed with the Harmonic Scalpel® (Ethicon Endo-Surgery Inc.) and standard 
laparoscopic techniques.  Total operative time was 320 minutes, estimated blood loss was 20 
mL, and the patient was discharged home on post-operative day 4.  Allograft function 
remained stable, radiographic resolution of obstruction was documented, and there were no 
recurrent episodes of infection at 12-month follow-up.  The authors concluded that robotic 
assistance allowed for efficient complex reconstruction without sacrificing the benefits of a 
minimally invasive approach. 
The above case reports highlight the potential role for robotic-assisted surgery in complex 
renal reconstructive procedures.  And while certainly none of these techniques will become 
routine practice in the foreseeable future, pushing the boundaries of current technology will 
undoubtedly help form the basis for future innovation.  Furthermore, exercises such as these 
will help define the collaborative role of open, laparoscopic, and robotic surgery in the 
future. 
8. Future Considerations 
Robotic surgery is still in its infancy.  The fields of urology, cardiac surgery, neurosurgery, 
orthopedics, and fetal surgery have already embraced this new technology with the 
ambition of advancing medical frontiers and application.  The goal of applied surgical 
robotics is improved patient care.  Through active clinical and laboratory experimentation, 
applications specific to robotic renal surgery will hopefully advance in parallel with other 
disciplines. 
Future invention and innovation with regards to surgical robotic technology currently 
evolves around a number of spheres.  At the forefront is improved visualization technology 
in the form of augmented reality and image guided surgery.  Enhanced real-time imaging 
has been proposed for the next generation surgical robot.101   Robotic ultrasound and 
acoustic holography may soon provide real-time imaging that can predict normal from 
abnormal tissues intraoperatively.  Robotic-enhanced haptic and temperature sensors may 
someday solve the problem of lack of haptic feedback with current surgical robots, and will 
likely mimic human tactile feeling with greater sensitivity and precision.102   Diagnostic 
sensors engaged on robotic arms may preclude the need for biopsy and pathological 
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analysis to detect cancer.  Lastly, collaboration between nanotechnology and microbiology 
may someday permit “DNA-assembly robots” to perform “surgery” on the molecular level 
analogous to the console surgeon with the da Vinci® system today.  A detailed synopsis on 
the future of robotic surgical technology is beyond the scope of this chapter.102  
The current status of any new or developed discipline can quickly be gleaned from the 
number of students trying to learn it.  The interest in acquiring laparoscopic skills, in 
general, and robotic skills, in particular, is evidenced by dramatic shifts in residency training 
programs.  In a survey of American and Canadian urology residents on laparoscopic and 
robotic surgery, 54% of respondents reported robotic surgery was being performed at their 
center.  Twenty-two percent of resident respondents had been trained in robotic surgery and 
34% anticipated performing robotic surgery upon completion of residency.  Questions in the 
survey addressed both robotic prostatectomy and pyeloplasty.103   In contrast, results of a 
similar survey of residents and practicing urologists published just two years prior did not 
even address robotic surgery.104   This observation highlights the shift in attitudes towards 
robotic surgery in urology in contemporary times.   
Although the future role of robotics in renal surgery is still unclear, robotic-assisted surgery 
in urology as it pertains to prostatectomy appears here to stay.  As a niche for robotic-
assisted pyeloplasty and partial nephrectomy continues to be carved out, interest in radical 
extirpative renal surgery appears to have waned in recent years.  And while there may be a 
role for robotic-assistance in complicated renal reconstructive procedures, this role has yet to 
be defined and for the time being consists solely of enlightening case reports.  Nonetheless, 
these are interesting times in the collaborative fields of both urology and robotics, and the 
next decade of research and exploration will likely clarify some of these issues as robotic 
technology continues to mature. Hopefully, through further education, technological 
advancement and commercial competition, surgical robotics will become more accessible to 
the majority of practicing urologists and their patients in the near future.  
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